CBD and CBG shielded rat brain cells from toxin damage, and a lone receptor seems to be why

A paper in ChemMedChem from researchers in Uruguay, Chile and Spain tested whether two non-intoxicating cannabinoids, CBD and CBG, can protect nerve cells from damage and, if so, how. They used cultured rat cerebellar granule neurons and exposed them to rotenone, a compound that disrupts mitochondria and is commonly used to mimic neuronal stress in the lab.

Both cannabinoids protected the cells. Their acidic raw forms, CBDA and CBGA, did not. The protection did not seem to depend on several cannabinoid targets that earlier work had examined. When the team blocked the sigma-1 receptor with a compound called NE-100, the protective effect of both CBD and CBG disappeared, which suggests that receptor is doing the work.

Computer simulations backed that up by predicting that both molecules sit stably in the receptor's binding pocket, with the neutral forms predicted to bind more tightly than the acidic ones. That fits the cell results, though the simulations are predictions rather than measured binding.

Keep the limits in view. This is cultured rat cells in a dish, one blocking compound supports the mechanism, and nothing here shows an effect in living animals or people. For brands, the honest takeaway is that neuroprotection claims on a CBD or CBG label are well ahead of the evidence, but the sigma-1 angle gives researchers a more specific lead to test in animals next.